Skip to content

Subsidies

Flemish government · Wallonia-Brussels Federation · federal government · European Union

Pick a company. You see which programmes comparable companies received over the last five years, how many of them, for what amount, and which the company itself did not receive.

BE 0774.472.942

ImmuneWatch

Research and development on biotechnology · Antwerp · Micro

Other company

Comparison group of 508 companies

The group is made of active legal entities with the same activity class (7210, Research and development on biotechnology), in Flanders. Their size is micro to small. The period starts in 2022.

  • Flemish subsidies 32% of comparable This company: €146,541 awarded, 3 programmes
  • Federal transfers 1.6% of comparable This company: nothing in this register
  • Wallonia-Brussels Federation 0% of comparable This company: nothing in this register
  • EU budget 6.1% of comparable This company: €1.0m attributed share, 1 programme
  • EU research 6.9% of comparable This company: €974,896 eu contribution, 1 programme

Programmes ImmuneWatch did not receive according to the registers

At least 2 comparable companies received these programmes since 2022. The most shared come first. That others received a programme does not say whether this company qualifies or whether the programme is still open. The Flemish register publishes the names of its programmes in Dutch only: they appear here as it publishes them.

20
  1. 5.9% 30 of 508 companies median €2,582 awarded
  2. 4.7% 24 of 508 companies median €41,439 awarded
  3. 4.3% 22 of 508 companies median €937,690 awarded
  4. 3.3% 17 of 508 companies median €336,095 awarded
  5. 2.2% 11 of 508 companies median €50,000 awarded
  6. 1.4% 7 of 508 companies median €11,605 awarded
  7. 1.2% 6 of 508 companies median €323,697 awarded
  8. 1.2% 6 of 508 companies median €50,000 awarded
  9. European Regional Development Fund EU budget, register at its source: European Commission, Financial Transparency System (opens the source's website)X - IEEA - Executive Agency for Small and Medium-sized Enterprises2023 to 2024no entry after 2024 (register runs to 2025)For example IQVIA Cancer Research, IDRO, Zymofix
    0.8% 4 of 508 companies median €606,510 attributed share
  10. 0.8% 4 of 508 companies median 118,500 amount as published
  11. 0.8% 4 of 508 companies median €109,378 awarded
  12. 0.8% 4 of 508 companies median €15,418 awarded
Show 8 more
  1. 0.6% 3 of 508 companies median €350,000 awarded
  2. 0.6% 3 of 508 companies median €325,823 attributed share
  3. 0.4% 2 of 508 companies median €710,822 awarded
  4. 0.4% 2 of 508 companies median €205,615 awarded
  5. 0.4% 2 of 508 companies median €79,184 awarded
  6. 0.4% 2 of 508 companies median €27,280 awarded
  7. 0.4% 2 of 508 companies median €17,803 awarded
  8. 0.4% 2 of 508 companies median €1,746 awarded

Programmes ImmuneWatch also received

5
  1. 20% 103 of 508 companies median €1,445 awarded
  2. 9.4% 48 of 508 companies median €9,000 awarded
  3. 6.9% 35 of 508 companies median €555,292 eu contribution
  4. 6.5% 33 of 508 companies median €432,565 awarded
  5. 5.3% 27 of 508 companies median €555,288 attributed share